These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23363487)

  • 1. Predicting intrinsic clearance for drugs and drug candidates metabolized by aldehyde oxidase.
    Jones JP; Korzekwa KR
    Mol Pharm; 2013 Apr; 10(4):1262-8. PubMed ID: 23363487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Laboratory-Specific Scaling Factor to Predict the In Vivo Human Clearance of Aldehyde Oxidase Substrates.
    De Sousa Mendes M; L Orton A; Humphries HE; Jones B; Gardner I; Neuhoff S; Pilla Reddy V
    Drug Metab Dispos; 2020 Nov; 48(11):1231-1238. PubMed ID: 32893186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel in vitro allometric scaling methodology for aldehyde oxidase substrates to enable selection of appropriate species for traditional allometry.
    Crouch RD; Hutzler JM; Daniels JS
    Xenobiotica; 2018 Mar; 48(3):219-231. PubMed ID: 28281401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme Kinetics, Pharmacokinetics, and Inhibition of Aldehyde Oxidase.
    Paragas EM; Choughule K; Jones JP; Barr JT
    Methods Mol Biol; 2021; 2342():257-284. PubMed ID: 34272698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges and Opportunities for In Vitro-In Vivo Extrapolation of Aldehyde Oxidase-Mediated Clearance: Toward a Roadmap for Quantitative Translation.
    Izat N; Bolleddula J; Abbasi A; Cheruzel L; Jones RS; Moss D; Ortega-Muro F; Parmentier Y; Peterkin VC; Tian DD; Venkatakrishnan K; Zientek MA; Barber J; Houston JB; Galetin A; Scotcher D
    Drug Metab Dispos; 2023 Dec; 51(12):1591-1606. PubMed ID: 37751998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro-in vivo correlation for intrinsic clearance for drugs metabolized by human aldehyde oxidase.
    Zientek M; Jiang Y; Youdim K; Obach RS
    Drug Metab Dispos; 2010 Aug; 38(8):1322-7. PubMed ID: 20444863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydralazine as a selective probe inactivator of aldehyde oxidase in human hepatocytes: estimation of the contribution of aldehyde oxidase to metabolic clearance.
    Strelevitz TJ; Orozco CC; Obach RS
    Drug Metab Dispos; 2012 Jul; 40(7):1441-8. PubMed ID: 22522748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative Prediction of Human Hepatic Clearance for P450 and Non-P450 Substrates from In Vivo Monkey Pharmacokinetics Study and In Vitro Metabolic Stability Tests Using Hepatocytes.
    Nishimuta H; Watanabe T; Bando K
    AAPS J; 2019 Jan; 21(2):20. PubMed ID: 30673906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldehyde oxidase and its role as a drug metabolizing enzyme.
    Dalvie D; Di L
    Pharmacol Ther; 2019 Sep; 201():137-180. PubMed ID: 31128989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-Directed Mutagenesis at the Molybdenum Pterin Cofactor Site of the Human Aldehyde Oxidase: Interrogating the Kinetic Differences Between Human and Cynomolgus Monkey.
    Abbasi A; Joswig-Jones CA; Jones JP
    Drug Metab Dispos; 2020 Dec; 48(12):1364-1371. PubMed ID: 33020066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldehyde oxidase mediated drug metabolism: an underpredicted obstacle in drug discovery and development.
    Gajula SNR; Nathani TN; Patil RM; Talari S; Sonti R
    Drug Metab Rev; 2022 Nov; 54(4):427-448. PubMed ID: 36369949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geometrical control of the active site electronic structure of pyranopterin enzymes by metal-dithiolate folding: aldehyde oxidase.
    Joshi HK; Enemark JH
    J Am Chem Soc; 2004 Sep; 126(38):11784-5. PubMed ID: 15382900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minipig and Human Metabolism of Aldehyde Oxidase Substrates: In Vitro-In Vivo Comparisons.
    Wilkinson DJ; Southall RL; Li M; Wright LM; Corfield LJ; Heeley TA; Bratby B; Mannu R; Johnson SL; Shaw V; Friett HL; Blakeburn LA; Kendrick JS; Otteneder MB
    AAPS J; 2017 Jul; 19(4):1163-1174. PubMed ID: 28474310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldehyde oxidase at the crossroad of metabolism and preclinical screening.
    Cheshmazar N; Dastmalchi S; Terao M; Garattini E; Hamzeh-Mivehroud M
    Drug Metab Rev; 2019 Nov; 51(4):428-452. PubMed ID: 31549868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of aldehyde oxidase: an enzyme of emerging importance in novel drug discovery.
    Rashidi MR; Soltani S
    Expert Opin Drug Discov; 2017 Mar; 12(3):305-316. PubMed ID: 28095715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug clearance by aldehyde oxidase: can we avoid clinical failure?
    Toselli F; Golding M; Nicolaï J; Gillent E; Chanteux H
    Xenobiotica; 2022 Aug; 52(8):890-903. PubMed ID: 36170034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of the novel, high-affinity and selective dopamine D3 receptor antagonist SB-277011 in rat, dog and monkey: in vitro/in vivo correlation and the role of aldehyde oxidase.
    Austin NE; Baldwin SJ; Cutler L; Deeks N; Kelly PJ; Nash M; Shardlow CE; Stemp G; Thewlis K; Ayrton A; Jeffrey P
    Xenobiotica; 2001; 31(8-9):677-86. PubMed ID: 11569533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges and Opportunities with Non-CYP Enzymes Aldehyde Oxidase, Carboxylesterase, and UDP-Glucuronosyltransferase: Focus on Reaction Phenotyping and Prediction of Human Clearance.
    Argikar UA; Potter PM; Hutzler JM; Marathe PH
    AAPS J; 2016 Nov; 18(6):1391-1405. PubMed ID: 27495117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of Exposure in a First-in-Man Study Due to Aldehyde Oxidase Metabolism: Investigated by Use of 14C-microdose, Humanized Mice, Monkey Pharmacokinetics, and In Vitro Methods.
    Jensen KG; Jacobsen AM; Bundgaard C; Nilausen DØ; Thale Z; Chandrasena G; Jørgensen M
    Drug Metab Dispos; 2017 Jan; 45(1):68-75. PubMed ID: 27737930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human aldehyde oxidase (hAOX1): structure determination of the Moco-free form of the natural variant G1269R and biophysical studies of single nucleotide polymorphisms.
    Mota C; Esmaeeli M; Coelho C; Santos-Silva T; Wolff M; Foti A; Leimkühler S; Romão MJ
    FEBS Open Bio; 2019 May; 9(5):925-934. PubMed ID: 30985987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.